NCT06861634View on ClinicalTrials.gov

Optimization of Morphinomimetic Administration Intraoperatively: Evaluation of the Impact of the NOL Index on the Occurrence of Postoperative Adverse Events Related to Morphinomimetics

NANot yet recruitingINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
AnesthesiaIntensive Care Medicine
Interventions
PROCEDURE

Nol index

Morphinomimetics will be administered according to NOL Index values or according to the usual criteria.

Trial Locations (6)

Unknown

Chu Angers, Angers

CH BLOIS, Blois

Chu Brest, Brest

Chu Nantes, Nantes

Chru Tours Sar1, Tours

Chru Tours Sar2, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT06861634 - Optimization of Morphinomimetic Administration Intraoperatively: Evaluation of the Impact of the NOL Index on the Occurrence of Postoperative Adverse Events Related to Morphinomimetics | Biotech Hunter | Biotech Hunter